Gilead Sciences, Inc. recalls Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Fo…
- Recall date
- September 19, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0005-2025
- FDA classification
- Class I
- Brand / firm
- Gilead Sciences, Inc.
- Sold / distributed
- Nationwide in the U.S.A.
Why it was recalled
Presence of Particulate Matter: Presence of glass particle.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2
Get recall alerts
Free email alert whenever Gilead Sciences, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Gilead Sciences, Inc.